These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20201860)

  • 1. Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse.
    Schmitt KC; Reith ME
    Ann N Y Acad Sci; 2010 Feb; 1187():316-40. PubMed ID: 20201860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid regulation of the dopamine transporter: role in stimulant addiction?
    Zahniser NR; Sorkin A
    Neuropharmacology; 2004; 47 Suppl 1():80-91. PubMed ID: 15464127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The dopamine transporter: characterization and physiopathologic implications].
    Thibaut F; Vaugeois JM; Petit M
    Encephale; 1995; 21(6):445-51. PubMed ID: 8674469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
    Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
    Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dopamine transporter proteome.
    Torres GE
    J Neurochem; 2006 Apr; 97 Suppl 1():3-10. PubMed ID: 16635244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.
    Seger D
    Clin Toxicol (Phila); 2010 Aug; 48(7):695-708. PubMed ID: 20849328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges.
    Eriksen J; Jørgensen TN; Gether U
    J Neurochem; 2010 Apr; 113(1):27-41. PubMed ID: 20085610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine transporter as a target molecule for psychostimulants.
    Sora I; Li B; Fumushima S; Fukui A; Arime Y; Kasahara Y; Tomita H; Ikeda K
    Int Rev Neurobiol; 2009; 85():29-33. PubMed ID: 19607959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment.
    Volz TJ; Fleckenstein AE; Hanson GR
    Addiction; 2007 Apr; 102 Suppl 1():44-8. PubMed ID: 17493052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluctuation of the dopamine uptake inhibition potency of cocaine, but not amphetamine, at mammalian cells expressing the dopamine transporter.
    Ukairo OT; Ramanujapuram S; Surratt CK
    Brain Res; 2007 Feb; 1131(1):68-76. PubMed ID: 17169338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation.
    Johnson LA; Furman CA; Zhang M; Guptaroy B; Gnegy ME
    Neuropharmacology; 2005 Nov; 49(6):750-8. PubMed ID: 16212991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine.
    Cunha-Oliveira T; Rego AC; Cardoso SM; Borges F; Swerdlow RH; Macedo T; de Oliveira CR
    Brain Res; 2006 May; 1089(1):44-54. PubMed ID: 16638611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
    Pifl C; Drobny H; Reither H; Hornykiewicz O; Singer EA
    Mol Pharmacol; 1995 Feb; 47(2):368-73. PubMed ID: 7870046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dopamine transporter: a crucial component regulating dopamine transmission.
    Jaber M; Jones S; Giros B; Caron MG
    Mov Disord; 1997 Sep; 12(5):629-33. PubMed ID: 9380041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive atlas of the topography of functional groups of the dopamine transporter.
    Volz TJ; Schenk JO
    Synapse; 2005 Nov; 58(2):72-94. PubMed ID: 16088952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficits.
    Volz TJ; Hanson GR; Fleckenstein AE
    J Neurochem; 2007 May; 101(4):883-8. PubMed ID: 17250674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.
    Lindsey KP; Wilcox KM; Votaw JR; Goodman MM; Plisson C; Carroll FI; Rice KC; Howell LL
    J Pharmacol Exp Ther; 2004 Jun; 309(3):959-69. PubMed ID: 14982963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic--A focus on analogues of benztropine and rimcazole.
    Newman AH; Kulkarni S
    Med Res Rev; 2002 Sep; 22(5):429-64. PubMed ID: 12210554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Increasing abuse of psychostimulants is alarming. New findings confirm the mechanisms behind cocaine and amphetamine addiction].
    Hurd Y; Lindefors N
    Lakartidningen; 1999 Apr; 96(15):1814-6, 1819-21. PubMed ID: 10319645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation.
    Gorentla BK; Vaughan RA
    Neuropharmacology; 2005 Nov; 49(6):759-68. PubMed ID: 16181646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.